FDA WARNING_LETTER_RESPONSE - Eli Lilly & Company - February 23, 2001

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This WARNING LETTER RESPONSE record concerns Eli Lilly & Company, with an inspection on February 23, 2001, issued by the Center for Devices and Radiological Health, covering devices.

Company: Eli Lilly & Company
Inspection Date: February 23, 2001
Product Type: Devices
Office: Center for Devices and Radiological Health
People: Thomas J. (Regulatory Counsel)
Judith A. Putz (Ms.)
Hung V. Le (Investigator)
Patricia Cochran
Jeffrey Sommers

Open in Dashboard

ID · e90881d9-e2fa-473e-ab9d-4415ee00f701

Violation Codes9

21 CFR 21021 CFR 211.2221 CFR 211.10021 CFR 211.113(b)21 CFR 211.16021 CFR 211.42(c)(5)21 CFR 211.42(b)21 CFR 211.6821 U.S.C. 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

WARNING LETTER RESPONSE

Eli Lilly & CompanyFebruary 23, 2001

FDA WARNING_LETTER_RESPONSE - Eli Lilly & Company - February 23, 2001

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This WARNING LETTER RESPONSE record concerns Eli Lilly & Company, with an inspection on February 23, 2001, issued by the Center for Devices and Radiological Health, covering devices.

Company: Eli Lilly & Company
Inspection Date: February 23, 2001
Product Type: Devices
Office: Center for Devices and Radiological Health
People: Thomas J. (Regulatory Counsel)
Judith A. Putz (Ms.)
Hung V. Le (Investigator)
Patricia Cochran
Jeffrey Sommers

Open in Dashboard

ID · e90881d9-e2fa-473e-ab9d-4415ee00f701

Violation Codes9

21 CFR 21021 CFR 211.2221 CFR 211.10021 CFR 211.113(b)21 CFR 211.16021 CFR 211.42(c)(5)21 CFR 211.42(b)21 CFR 211.6821 U.S.C. 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.